Gene · 29949
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs). | J Immunol Res | 2022 | 35378905 | PubTator, text mining | PubMed |
| Combination of FLG mutations and SNPs of IL-17A and IL-19 influence on atopic dermatitis occurrence. | Postepy Dermatol Alergol | 2022 | 35369616 | PubTator, text mining | PubMed |
| Salivary Microbiota and Host-Inflammatory Responses in Periodontitis Affected Individuals With and Without Rheumatoid Arthritis. | Front Cell Infect Microbiol | 2022 | 35360114 | PubTator, text mining | PubMed |
| NVCL-Based Galacto-Functionalized and Thermosensitive Nanogels with GNRDs for Chemo/Photothermal-Therapy. | Pharmaceutics | 2022 | 35335936 | PubTator, text mining | PubMed |
| Early Immune Response in Foreign Body Reaction Is Implant/Material Specific. | Materials (Basel) | 2022 | 35329646 | PubTator, text mining | PubMed |
Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage. | Arch Med Sci | 2022 | 35316898 | PubTator, text mining | PubMed |
| High Relaxivity with No Coordinated Waters: A Seemingly Paradoxical Behavior of [Gd(DOTP)]5- Embedded in Nanogels. | Inorg Chem | 2022 | 35316037 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 35299868 | PubTator, text mining | PubMed |
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects. | Arch Gynecol Obstet | 2022 | 35298675 | PubTator, text mining | PubMed |
| Regulatory T Cells in Autoimmune Vasculitis. | Front Immunol | 2022 | 35296082 | PubTator, text mining | PubMed |
| Interleukin-19 Aggravates Pulmonary Fibrosis via Activating Fibroblast through TGF-β/Smad Pathway. | Mediators Inflamm | 2022 | 35281428 | PubTator, text mining | PubMed |
| A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis. | Front Med (Lausanne) | 2022 | 35280877 | PubTator, text mining | PubMed |
| Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. | Sci Rep | 2022 | 35277538 | PubTator, text mining | PubMed |
| Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets. | Int J Mol Sci | 2022 | 35269828 | PubTator, text mining | PubMed |
| Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis. | Int J Mol Sci | 2022 | 35269649 | PubTator, text mining | PubMed |
| Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights. | Nutrients | 2022 | 35267943 | PubTator, text mining | PubMed |
| The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. | Cancers (Basel) | 2022 | 35267668 | PubTator, text mining | PubMed |
| Novel Therapeutic Target(s) for Psoriatic Disease. | Front Med (Lausanne) | 2022 | 35265634 | PubTator, text mining | PubMed |
| In Vitro Disease Models for Understanding Psoriasis and Atopic Dermatitis. | Front Bioeng Biotechnol | 2022 | 35265594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29949/papers?page=26